COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patient’s protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine visits are available for routine office visits. All Patients – Very Important: Regardless of vaccination status.  If you are experiencing a fever or cold-like like symptoms, which also include GI Symptoms and Diarrhea, you should contact your Virginia Cancer Specialists Advice Line before visiting our clinics for scheduled appointments. This includes symptoms of respiratory illness, such as coughing or difficulty breathing.  More Information-PLEASE CLICK HERE

Keeran R. Sampat, MD

VCS Physicians

Keeran R. Sampat, MD Headshot

Compassion for patients and excitement for scientific breakthroughs have always motivated me as an oncologist. I feel privileged to treat patients with challenging diseases with an expanding array of effective therapies.

Work and Credentials:

Primary Location

Arlington Office


Medical Oncologist

Board Certification

Medical Oncology, Hematology, and Internal Medicine


University of North Carolina at Chapel Hill, Medical Oncology and Hematology; MD Anderson Cancer Center, Leukemia


The University of Texas Medical School at Houston


The University of Texas Medical School at Houston

Medical School

University of Virginia


University of Virginia

A graduate of the University of Virginia Medical School, Dr. Sampat completed his Internal Medicine residency at the University of Texas – Houston and then spent one year completing a Leukemia fellowship at MD Anderson Cancer Center. He completed his Hematology & Medical Oncology fellowship at the University of North Carolina. Dr. Sampat’s education and training reflect a particular interest in advancing treatment options for patients with gastrointestinal malignancies. He has contributed to several publications and presentations in this field. Dr. Sampat stays active in the medical community through his memberships in associations such as the American Society of Clinical Oncology and the American Society of Hematology.

In his spare time, Dr. Sampat enjoys hiking, bicycling, and traveling.

Practice Blog

March 29, 2021

Colorectal Cancer Awareness - Keeran Sampat, MD

Read More
March 14, 2019

Keeran Sampat MD on ABC7 WJLA News, Pancreatic Cancer Alex Trebek

Read More

Physician Publications

April 10, 2013

Antiangiogenic therapies for advanced hepatocellular carcinoma

Read More
February 1, 2013

Pleural effusions in patients with acute leukemia and myelodysplastic syndrome

Read More
June 1, 2011

Does pretreatment fluorescence in situ hybridization for BCR-ABL predict imatinib-associated hematologic toxicity in chronic myeloid leukemia?

Read More

More Publications by Keeran R. Sampat, MD

January 1, 2011

Whole Gene Expression Profiling in Ankylosing Spondylitis Shows Upregulation of Toll-Like Receptor 4 and 5

Read More
May 15, 2010

Characteristics of pericardial effusions in patients with leukemia.

Read More
October 1, 2009

Clofarabine: Emerging Role in Leukemias

Read More

Clinical Trials (1)

Clinical Trial USOR 21242

A Phase 2 Multicenter, Randomized, Parallel Group Study to Establish the Efficacy and Safety of Combinations of CBP501, Cisplatin, and Nivolumab for > or = 3rd Line Treatment of Patients with Exocrine Pancreatic Cancer and WBC <10,000 at Screening

Primary Location

Arlington Office Office

Arlington Office

Learn More

Other Locations